Literature DB >> 7018164

A double-blind study of the value of treatment with a single dose tinidazole of partners to females with trichomoniasis.

J Lyng, J Christensen.   

Abstract

Tinidazole 2 g single oral dose was given to 137 females with positive trichomonal cultures. On a random basis the same dose of tinidazole was given to half the sexual partners, and matching placebo to the other half. One to two weeks after treatment 5 females had positive cultures, indicating a primary cure rate of 96.4%. At an average of 2 months after treatment and 6 weeks after resuming sexual activity, 118 females were reexamined; 17 had a positive culture, giving an overall relapse rate of 14.4%. The relapse rate with tinidazole-treated partner was 5.1%, and with placebo-treated partner 23.7% (p equals 0.01). The definitive cure rate after a single dose of tinidazole 2 g was in females with treated partner 91.8% and with untreated partner 72.6%. It is concluded that a single dose of tinidazole is an effective treatment for females with trichomoniasis but to avoid relapse it is necessary to treat the sexual partner too.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7018164

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  11 in total

1.  Trichomonas vaginalis infection.

Authors:  D Mabey; J Ackers; Y Adu-Sarkodie
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

2.  Improving Women's Health and Combatting Sexually Transmitted Infections Through Expedited Partner Therapy.

Authors:  Cornelius D Jamison; Jenell S Coleman; Okeoma Mmeje
Journal:  Obstet Gynecol       Date:  2019-03       Impact factor: 7.661

3.  Epidemiology and treatment of trichomoniasis.

Authors:  Patricia Kissinger
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

Review 4.  Drug treatment of nonviral sexually transmitted diseases: specific issues in adolescents.

Authors:  C E Lehmann; F M Biro
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 5.  Randomized controlled trials of interventions to prevent sexually transmitted infections: learning from the past to plan for the future.

Authors:  Catherine M Wetmore; Lisa E Manhart; Judith N Wasserheit
Journal:  Epidemiol Rev       Date:  2010-06-02       Impact factor: 6.222

6.  Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.

Authors:  Patricia J Kissinger; Charlotte A Gaydos; Arlene C Seña; R Scott McClelland; David Soper; W Evan Secor; Davey Legendre; Kimberly A Workowski; Christina A Muzny
Journal:  Clin Infect Dis       Date:  2022-04-13       Impact factor: 20.999

Review 7.  Preventing complications of sexually transmitted disease. New treatment guidelines for an expanded spectrum of problems.

Authors:  A E Washington
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

8.  Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.

Authors:  R Scott McClelland; Barbra A Richardson; Wisal M Hassan; Vrasha Chohan; Ludo Lavreys; Kishorchandra Mandaliya; James Kiarie; Walter Jaoko; Jeckoniah O Ndinya-Achola; Jared M Baeten; Ann E Kurth; King K Holmes
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

9.  Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis.

Authors:  D E Nix; R Tyrrell; M Müller
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

10.  Bacterial vaginosis and trichomoniasis: epidemiology and management of recurrent disease.

Authors:  D E Soper
Journal:  Infect Dis Obstet Gynecol       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.